Company Filing History:
Years Active: 1999-2003
Title: Innovations of Yuri Lazebnik
Introduction
Yuri Lazebnik is a notable inventor based in East Norwich, CT (US). He has made significant contributions to the field of biomedical research, particularly in the study of apoptosis and its implications in various diseases. With a total of 3 patents, his work focuses on identifying compounds that can modulate apoptosis in transformed cells.
Latest Patents
One of his latest patents is titled "Cell-free assay using oncogene-induced apoptosis to identify inhibitors of apoptosis in drug-resistant cells." This invention relates to a method for identifying compounds that can selectively activate or inhibit apoptosis in transformed cells. The patent outlines a process for selectively killing transformed cells by using compounds that activate apoptosis. Additionally, it provides methods for treating diseases associated with defective apoptotic machinery, such as cancer and neurodegenerative diseases like Huntington's Disease and Alzheimer's Disease. The invention also includes an assay to identify compounds that modulate apoptosis, which could lead to new drug developments targeting these diseases.
Career Highlights
Yuri Lazebnik is affiliated with Cold Spring Harbor Laboratory, where he conducts his research. His work has been instrumental in advancing the understanding of apoptosis and its role in various diseases. His innovative approaches have opened new avenues for therapeutic interventions.
Collaborations
Some of his notable coworkers include Howard O. Fearnhead and Mila Elena McCurrach. Their collaborative efforts contribute to the ongoing research and development in the field of apoptosis and cancer treatment.
Conclusion
Yuri Lazebnik's contributions to the field of biomedical research through his patents and collaborations highlight the importance of innovation in understanding and treating complex diseases. His work continues to inspire advancements in medical science.